title: Novel tamarind seed polysaccharide-alginate mucoadhesive microspheres for oral gliclazide delivery: in vitro-in vivo evaluation.
abstract: Novel tamarind seed polysaccharide (TSP)-alginate mucoadhesive microspheres were prepared using TSP and alginate as blend in different ratios with different calcium chloride (CaCl(2)) concentration as a cross linker by ionotropic gelation. The prepared microspheres were of spherical shape having rough surfaces, and average particle sizes within the range of 752.12 ± 6.42 to 948.49 ± 20.92 µm. The drug entrapment efficiency of these microspheres were within the range between 58.12 ± 2.42 to 82.78 ± 3.43% w/w. Fourier transform infrared (FTIR) studies indicated that there were no reactions between gliclazide, and polymers (TSP, and sodium alginate) used. Different formulations of gliclazide loaded TSP-alginate microspheres showed prolonged in vitro release profiles of gliclazide over 12 hours in both stomach pH (pH 1.2), and intestinal pH (pH 7.4). It was found that the gliclazide release in gastric pH was comparatively slow and sustained than intestinal pH. These TSP-alginate microspheres also exhibited good mucoadhesivity. The in vivo studies on alloxan-induced diabetic rats (Animal Ethical Committee registration number: IFTM/837ac/0160) demonstrated the significant hypoglycemic effect of selected formulation of TSP-alginate mucoadhesive microspheres containing gliclazide on oral administration. This developed gliclazide loaded new TSP-alginate mucoadhesive microspheres may be very much useful for prolonged systemic absorption of gliclazide for proper maintaining blood glucose level and advanced patient compliance.
authors.affiliation: Faculty of Pharmacy, The University of Sydney, NSW, Australia. drdilip2003@yahoo.co.in
authors.forename: Dilipkumar
authors.initials: D
authors.lastname: Pal
authors.forename: Amit Kumar
authors.initials: AK
authors.lastname: Nayak
mesh_terms: D000284:Administration, Oral; D000464:Alginates / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism; D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005260:Female; D005907:Gliclazide / Q000008:administration & dosage* / Q000378:metabolism; D020723:Glucuronic Acid / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism; D006041:Goats; D006603:Hexuronic Acids / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008863:Microspheres; D010936:Plant Extracts / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism; D011134:Polysaccharides / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism; D051381:Rats; D012639:Seeds; D029861:Tamarindus; D014014:Tissue Adhesives / Q000008:administration & dosage* / Q000302:isolation & purification / Q000378:metabolism
chemical_list: D000464:Alginates; D006603:Hexuronic Acids; D010936:Plant Extracts; D011134:Polysaccharides; D014014:Tissue Adhesives; D020723:Glucuronic Acid; D005907:Gliclazide